Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy

Bioretec Ltd  Company announcement 11 December 2023 at 5:15 p.m. EETIn the future, in addition to the financial statements bulletin and half-year report, Bioretec will also publish business reviews for January–March and January–September. As a result, Bioretec Ltd has updated its disclosure policy describing the general principles and procedures that the company adheres to in its communication with capital markets and financial media.   The updated disclosure policy is available on the company’s web pages at https://bioretec.com/investors/investors-in-english/investor-relations/

Safello terminates services agreement with Finshark AB

Stockholm, 11 December 2023 | Safello, the leading cryptocurrency exchange in the Nordics, has terminated the agreement with Swedish payment service provider Finshark with immediate effect. The agreement was entered into on 11 July 2023 for the purpose of providing Safello with payment initiation services for instant payments and payouts, but the services have not been taken into active use.  ### For more information, please contactLouise Andersson, press@safello.com Certified AdviserAmudova AB is Safello’s certified adviser. Safello is the leading cryptocurrency exchange in

Observe Medical ASA - Exercise of subscription rights and over-subscription by primary insider and close associate of primary insider

Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 27 November 2023 regarding the allocation of subscription rights (the "Subscription Rights") in the rights issue ("Rights Issue") to primary insiders and close associates. US Holding AS, a closely associated person of primary insider Rune Nystad which is CEO in the Company, has exercised 384,615 Subscription Rights, entitling US Holding AS to be allocated 384,615 offer shares in the Rights Issue at a price per offer share of NOK 0.26, subject to the Rights Issue being completed. For

Neste partners with Coleman Oil Company to make renewable diesel more widely available in Washington State

Neste Corporation, News, 11 December 2023 Photo: Coleman Oil truck in Washington State. Source: Coleman OilNeste has partnered with Coleman Oil Company, a leading provider of fuels, biofuels, lubricants, and related products, to enable cities and businesses to have easier access to Neste MY Renewable Diesel™  in the state of Washington in the U.S. This partnership expands the availability of Neste MY Renewable Diesel to key locations in Coleman Oil’s network of commercial fueling stations and other distribution channels, such as

Hamlet BioPharma is inviting you to join a digital presentation at Invest Live, Tuesday December 12[th] at 12.00 CET

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along with an extensive project and patent portfolio, is delighted toinvite you to join a presentation at Invest Live, on Tuesday December 12[th]  at 12.00 CET. Gain insights into the company´s latest progress within its infectious disease and cancer therapy, which includes 'Fast Track' status for the company´s cancer-drug Alpha1H. We welcome share holders, investors and other interested parties to join the presentation and discussion. The

Calliditas Receives Notice of Allowance for United States Patent Application Covering TARPEYO®

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 18/100,396 entitled “New Pharmaceutical Compositions.”  This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed.The allowed claims cover a method of treating IgA nephropathy with a composition that encompasses TARPEYO® (budesonide) delayed release capsules, developed under the name “NEFECON®”.

Technical News 3/23 – Spotlight Stock Market migration path to INET

Spotlight Stock Market will change trading system to INET Nordic provided by Nasdaq on February 1st, 2024. Two weeks prior to the migration, instrument and order management activities are conducted to ensure a smooth migration. January 18[th] · Instrument data related to instruments admitted to trading or traded on market where Spotlight Stock Market AB [1] is the market operator in Elasticia are updated in Nasdaq test environment, INET Test (NTF) and GCF TST and INET Production. · Orderbooks IDs are set in INET Test and Production systems. January 19[th] – January 31[st]

Christian Landau appointed as the new Director of Pemamek's Heavy Equipment segment

Christian Landau has been appointed to lead Pemamek's heavy equipment segment. Pemamek has appointed Christian Landau as the new Director of the Heavy Equipment segment, effective from December 1, 2023. Heavy Equipment is one of Pemamek's six business sectors. In recent years, there has been significant global demand for robotic solutions, and with this appointment, Pemamek aims to strengthen its position in the industry. In his new role as the Director of the Heavy Equipment segment, Christian will be responsible for the segment's strategy, developing partnerships, and

Scandinavian ChemoTech push forward previously communicated target of 15 commercial installations in India to Q1-2024

ChemoTech expects to sign three new commercial contracts in Q4-2023, in addition to the three already communicated, thereby pushing the previous stated target of 15 commercial contracts in India during Q4-2023 to Q1-2024.The reason for postponing the goal of 15 commercial installations in India to Q1-2024 is linked to delays in negotiations as a result of the recent cyclone “Michaung” in the Chennai area.   “The discussions and contract signings are taking somewhat longer due to this external event, but is by no means affected in terms of how they are progressing. We have not lost one

Wärtsilä is again included in the Dow Jones Sustainability Index

Wärtsilä Corporation, News, 11 December 2023 at 15.30 EETTechnology group Wärtsilä has for the eighth consecutive time been selected as an index component of the Dow Jones Sustainability Index Europe (DJSI). The company was assessed based on its 2022 performance and was ranked within the top three percent of its peers in the IEQ Machinery and Electrical Equipment sector with a total score of 63/100. The results were announced on 8 December 2023. Receiving the recognition for the eighth time in a row underlines Wärtsilä’s holistic approach and long-term commitment to sustainability. This

Buy-backs of shares in SSAB during week 49 2023

During the period 04 - 08 December 2023, SSAB AB (publ) (LEI 529900329VS14ZIML164) has repurchased in total 2,049,000 own shares, of which 508,000 shares of series A (ISIN: SE0000171100) and 1,541,000 shares of series B (ISIN: SE0000120669), as part of the share buy-back program initiated by the Board of Directors with the purpose to adjust the company’s capital structure so as to create greater value for the company’s shareholders.The share buy-back program, which SSAB announced on 25 October 2023 and which runs between 26 October 2023 and 11 March 2024, at the latest, is being carried out

Lagercrantz acquires DP Seals Ltd

Lagercrantz has today acquired DP Seals Ltd, a leading supplier of rubber sealings and mouldings for high specification applications.DP Seals designs and manufactures customised rubber seals, gaskets and mouldings, with intricate geometries to the highest quality. In-house tooling design and manufacturing enables the company to produce parts meeting the requirements of the most demanding industrial equipment manufacturers. Applications such as aerospace programs, subsea energy connections and Formula 1 racing cars typically require the use of rubber compounds that can withstand extreme

Form 8.3 - Dechra Pharmaceuticals plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION (a) Full name of discloser: Magnetar Capital Partners LP(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):    The naming of nominee or vehicle companies isinsufficient.  For a trust, the trustee(s),settlor and beneficiaries must be named.(c) Name of offeror/offeree in relation to whose Dechra

Gradientech announces oversubscribed rights issue

Gradientech AB (publ) announces that the company's rights issue, for which the subscription period ended on December 6, 2023, has been completed. The issue was oversubscribed amounting to a total of approximately 107 percent. Through the issue, Gradientech will receive the maximum planned amount of approximately SEK 25.8 million before deduction of issue costs.“To oversubscribe a rights issue, without guarantors, in the current strained financing climate, is both gratifying and an acknowledgment that we have many shareholders who think that we both have a promising product and that we

Change in the composition of Ahlstrom’s Board of Directors

AHLSTROM OYJ, PRESS RELEASE, DECEMBER 11, 2023 at 15:00 EET Jyrki Vainionpää has been appointed as a member of Ahlstrom’s Board of Directors as of December 11, 2023. Jyrki, who is independent of the company and non-independent of its significant shareholders, also assumes the role of President and CEO of A. Ahlström Corporation as of December 11. Lasse Heinonen, who left the position as President and CEO of A. Ahlström Corporation, on December 8, leaves his position as a member of Ahlstrom’s Board of Directors. Jyrki is also a board member in Terrafame, a company that supplies

Observe Medical ASA: Exercise of subscription rights and over-subscription by primary insider and close associate of primary insider

Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 27 November 2023 regarding the allocation of subscription rights (the "Subscription Rights") in the rights issue ("Rights Issue") to primary insiders and close associates. ELI AS, a closely associated person of primary insider Eskild Endrerud which is a board member in the Company, has exercised 6,897,850 Subscription Rights, entitling ELI AS to be allocated 6,897,850 offer shares in the Rights Issue at a price per offer share of NOK 0.26, subject to the Rights Issue being completed.

Axactor ASA: Extraordinary general meeting

Today, Axactor ASA held an extraordinary general meeting, as notified on 17 November 2023 through a stock exchange notice. The extraordinary general meeting approved the proposal from the nomination committee, to appoint Ørjan Svanevik as a new member to the board of directors, until the annual general meeting in 2025. After the general meeting, the board has the following composition: Terje Mjøs as chair, and Brita Eilertsen, Lars Erich Nilsen, Kjersti Høklingen and Ørjan Svanevik as board members. The minutes from the meeting are enclosed, and available at the company’s website.

Glaston Oyj Abp - Managers' Transactions

Glaston Corporation     Stock Exchange Release, Managers' Transactions 11.12.2023 at 14.30Glaston Oyj Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Veli-Matti ReinikkalaPosition: Member of the Board/Deputy member Issuer: Glaston Oyj AbpLEI: 743700V3I7CLI3DJ8L62Notification type: INITIAL NOTIFICATIONReference number: 45757/7/6 ____________________________________________Transaction date: 2023-12-07Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000369657Nature of

Gabather AB broadens the scope of EEG data analysis generated during the target engagement study by partnering with MINDIG

Gabather AB has partnered with MINDIG , a French company with an interdisciplinary team of data scientists, neurologists, and software engineers collaboratively pushing the boundaries of Electroencephalographic (EEG) analysis and neuroscience. The team at MINDIG will conduct a comprehensive and in-depth analysis of the extensive EEG data generated during the EEG/fMRI target engagement study with our lead candidate, GT-002, involving human healthy volunteers. Leveraging MINDIG's top-tier expertise and extensive experience in human brain analysis, this

Notice convening the Extraordinary General Meeting of SAS AB

Shareholders in SAS AB (publ) (hereinafter “SAS” or the “Company”) are hereby invited to attend the Extraordinary General Meeting on Wednesday 10 January 2024. The Extraordinary General Meeting will be held at 2:00 p.m. at the Company’s Head Office, Frösundaviks allé 1, Solna, Sweden. The meeting venue will open at 1:00 p.m. for registration. Registration of participants at the meeting ends when the meeting is called to order. The Board has decided that the shareholders shall also be able to exercise their voting rights at the Extraordinary General Meeting by postal voting in accordance

Updated Fleet

12 new loaders are coming to the Kiruna mine. An agreement has been signed between LKAB and Sandvik, and the ink has barely dried. The first delivery is expected in early 2024. "This is an important investment for better flexibility and safe and efficient production," says Joel Kangas, mine manager at LKAB in Kiruna.The agreement includes 12 loaders, all of which are to be equipped for autonomous operation via remote control. Seven of the vehicles are electric and five are diesel powered."This investment will ensure greater stability in production, round the clock. This means, for

Calmark signs distributor agreement with Techno Orbits in Saudi Arabia

Calmark Sweden AB announced today that an exclusive distributor agreement has been signed with the company Techno Orbits in Saudi Arabia regarding Calmark's bilirubin test for newborns.Techno Orbits was founded in 2007 and is a well-established and successful company with a large market share and extensive experience in the medical technology industry. Company is headquartered in Riyadh and several branches in Saudi Arabia and Amman. The company has approximately 150 employees and has good contacts with the Ministry of Health. Techno Orbits is the market leader in PNA testing and has

There are no items matching the current filter
There are no more items matching the current filter
Back to top